COO vs. WST, ALGN, XRAY, MMSI, HAE, QDEL, NEOG, ICUI, STAA, and ATRI
Should you be buying Cooper Companies stock or one of its competitors? The main competitors of Cooper Companies include West Pharmaceutical Services (WST), Align Technology (ALGN), DENTSPLY SIRONA (XRAY), Merit Medical Systems (MMSI), Haemonetics (HAE), QuidelOrtho (QDEL), Neogen (NEOG), ICU Medical (ICUI), STAAR Surgical (STAA), and Atrion (ATRI). These companies are all part of the "health care supplies" industry.
West Pharmaceutical Services (NYSE:WST) and Cooper Companies (NASDAQ:COO) are both large-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, community ranking, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends.
West Pharmaceutical Services has a net margin of 19.42% compared to West Pharmaceutical Services' net margin of 9.11%. Cooper Companies' return on equity of 20.57% beat West Pharmaceutical Services' return on equity.
West Pharmaceutical Services has higher earnings, but lower revenue than Cooper Companies. West Pharmaceutical Services is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.
Cooper Companies received 347 more outperform votes than West Pharmaceutical Services when rated by MarketBeat users. Likewise, 66.56% of users gave Cooper Companies an outperform vote while only 55.74% of users gave West Pharmaceutical Services an outperform vote.
West Pharmaceutical Services has a beta of 1.05, suggesting that its stock price is 5% more volatile than the S&P 500. Comparatively, Cooper Companies has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500.
In the previous week, Cooper Companies had 15 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 24 mentions for Cooper Companies and 9 mentions for West Pharmaceutical Services. Cooper Companies' average media sentiment score of 1.06 beat West Pharmaceutical Services' score of 0.67 indicating that West Pharmaceutical Services is being referred to more favorably in the media.
93.9% of West Pharmaceutical Services shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 0.5% of West Pharmaceutical Services shares are owned by insiders. Comparatively, 2.0% of Cooper Companies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
West Pharmaceutical Services presently has a consensus price target of $435.20, indicating a potential upside of 31.32%. Cooper Companies has a consensus price target of $111.42, indicating a potential upside of 18.14%. Given Cooper Companies' stronger consensus rating and higher possible upside, equities research analysts plainly believe West Pharmaceutical Services is more favorable than Cooper Companies.
Summary
West Pharmaceutical Services beats Cooper Companies on 11 of the 18 factors compared between the two stocks.
Get Cooper Companies News Delivered to You Automatically
Sign up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding COO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cooper Companies Competitors List
Related Companies and Tools
